Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Says PCR Products Boost Q3 Life Science Sales

Premium

Bio-Rad Laboratories this week reported a 2 percent increase in its third-quarter revenues, to $471.5 million from $461.1 million in the comparable period of 2009.

Sales for the company's life science segment increased 2 percent to $153.2 million, while clinical diagnostics sales were also up around 2 percent to $314.9 million. Clinical diagnostic sales include $13.6 million from the Biotest business, which Bio-Rad acquired in the first quarter of 2010.

The company said in a statement that the life science segment "benefited from strong sales of core product lines," including its next-generation CFX96 real-time PCR detection system and associated reagents.

Bio-Rad posted net income of $44.8 million, or $1.59 per share, versus net income of $38.5 million, or $1.38 per share, for the prior-year period.

Third-quarter R&D spending increased around 9 percent to $42.9 million from $39.5 million, while SG&A expenses fell 3 percent to $148.7 million from $153.6 million.

Bio-Rad finished the quarter with $630.6 million in cash and cash equivalents and $107.4 million in short-term investments.

The firm expects organic revenue growth for full-year 2010 to be in the 4 percent to 5 percent range. The company expects to report fourth-quarter sales of between $510 million and $520 million.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.